Concepedia

Olga Kondrashova

OK

Statistics

Publications

20

Citations

1.6K

H-Index

19

Active since

2015

Affiliations

QIMR Berghofer Medical Research Institute(Current)

The University of Melbourne

The University of Queensland

Peter MacCallum Cancer Centre

Walter and Eliza Hall Institute of Medical Research

Olga Kondrashova is an author at QIMR Berghofer Medical Research Institute specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2015–2024

20

Publications

20

Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Olga Kondrashova, Minh Nguyen, Kristy Shield‐Artin et al. · Cancer Discovery · 2017 · 417 citations · Full text

, , +17

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

, , +17

CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

Elaine Sanij, Katherine M. Hannan, Jiachen Xuan et al. · Nature Communications · 2020 · 219 citations · Full text

, , +17

The role of aberrant DNA methylation in cancer initiation and clinical impacts

Franziska Geissler, Ksenija Nesic, Olga Kondrashova et al. · Therapeutic Advances in Medical Oncology · 2024 · 91 citations · Full text

, , +17

Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

Ksenija Nesic, Olga Kondrashova, Rachel M. Hurley et al. · Cancer Research · 2021 · 86 citations · Full text

, , +17

1–5 of 20